Open AccessComparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy
Author(s) -
Sreenivasan Srirangaraj,
D Venkatesha
Publication year - 2011
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.83533
Subject(s) - lymphocyte , immunology , medicine , antiretroviral therapy , lymphocyte subsets , human immunodeficiency virus (hiv) , t cell , immune system , viral load
The high cost of CD4 count estimation in resource-limited settings is a major obstacle in initiating patients on highly active antiretroviral therapy (HAART). Thus, there is a need to evaluate other less expensive surrogate markers like total lymphocyte count (TLC) and absolute lymphocyte count (ALC).